Subscribe for $2

Subscribe for 2 $

Institutional-grade intelligence for professional investors

LIVE

•Real-time feeds•Global markets•24/7 coverage

Novartis Aktie News & Pressemeldungen

Novartis Eulerpool News

January 3 · Pharma

Novartis and Voyager Therapeutics: New partnership in gene therapy finalized.

January 8 · Pharma

Novartis reports success: Positive study results for Scemblix

April 10 · Pharma

Novartis cuts 700 jobs: Savings program hits research!

April 30 · Pharma

MorphoSys: Loss Multiplied, Novartis Deal On Track

July 19 · Business

Novartis Insists on High Price for New Cancer Drug Pluvicto

1

2

3

4

1

2

3

4

Novartis Stock News

Novartis is being monitored by journalists and investors worldwide. We gather the latest Novartis news here.

August 19 ·
SeekingAlpha
Columbia Pyrford International Stock Fund Q2 2025 Commentary
August 18 ·
Yahoo
Atropos Health Enters into Strategic Collaboration to Reduce Time to Rare Disease Diagnosis with Artificial Intelligence (AI) Algorithm
August 18 ·
Yahoo
New Novartis ESC data highlights strength of cardiovascular portfolio
August 18 ·
Yahoo
Geron Corporation Names Harout Semerjian as New CEO to Lead Commercialization of RYTELO
August 15 ·
Yahoo
2 Dividend Stocks to Buy and Hold
August 13 ·
SeekingAlpha
Scholar Rock Holding: Upcoming Milestone Approaches
August 12 ·
SeekingAlpha
MoonLake Immunotherapeutics: Maintaining A Small Holding
August 12 ·
Yahoo
Quantified Named to 2025 Inc. 5000, One of the 50 Fastest-Growing AI Firms in the U.S.
August 12 ·
Yahoo
Novartis scores again with third ianalumab Phase III victory
August 12 ·
Yahoo
Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda

1

2

1

2

Novartis Stock Press Releases

Novartis regularly publishes news on the company's website that are relevant for investors.

Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan